High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
- PMID: 8138251
High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
Abstract
We studied the development of liver tumors in male HBx gene transgenic mice. Of two lineages studied, in the lineage with the lowest HBx gene expression liver tumors developed only in an incidence comparable with that in normal CD-1 strain, whereas 84% of male mice with a high level of the HBx gene product succumbed to liver neoplasia, indicating that continued HBx gene expression higher than a certain threshold level may be necessary for the development of hepatic neoplasia. Sixty-five mice from a lineage with a high level of HBx expression were then followed throughout their 24-mo lifespan. The livers of transgenic mice showed foci of cellular alteration with cytoplasmic vacuolations around the central veins from the age of 2 mo, but these foci did not expand progressively by the age of 12 mo. Immunostaining demonstrated such hepatocytes had higher expression of HBx protein than surrounding cells. Neoplastic lesions including liver cell adenomas and hepatocellular carcinomas developed from the age of 13 mo. By bromodeoxyuridine labeling analysis, hepatocytes in altered foci were found to have increased DNA synthesis, whereas no labeling was observed in age- and sex-matched nontransgenic littermate controls. Furthermore, DNA content analysis revealed the existence of several small aneuploid peaks in the transgenic liver before the age of tumor development. These results suggest that the continued expression of HBx gene may initiate a complex process to hepatocellular carcinoma by inducing DNA synthesis and placing large numbers of hepatocytes subjective to secondary events for transformation.
Similar articles
-
HBx gene of hepatitis B virus induces liver cancer in transgenic mice.Nature. 1991 May 23;351(6324):317-20. doi: 10.1038/351317a0. Nature. 1991. PMID: 2034275
-
Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice.Cancer Res. 1991 Feb 15;51(4):1278-85. Cancer Res. 1991. PMID: 1847661
-
Hepatic preneoplasia in hepatitis B virus transgenic mice.Hepatology. 1994 Nov;20(5):1162-72. Hepatology. 1994. PMID: 7927248
-
[Transgenic mouse model for hepatocellular carcinoma in human hepatitis B virus infection].Nihon Rinsho. 1993 Feb;51(2):536-41. Nihon Rinsho. 1993. PMID: 8385245 Review. Japanese.
-
Transgenic mouse models of human gastric and hepatic carcinomas.Semin Cancer Biol. 1994 Feb;5(1):61-8. Semin Cancer Biol. 1994. PMID: 8186389 Review.
Cited by
-
Modeling hepatitis B virus infection, immunopathology and therapy in mice.Antiviral Res. 2015 Sep;121:1-8. doi: 10.1016/j.antiviral.2015.06.012. Epub 2015 Jun 19. Antiviral Res. 2015. PMID: 26099683 Free PMC article. Review.
-
Nucleotide changes related to hepatocellular carcinoma in the enhancer 1/x-promoter of hepatitis B virus subgenotype C2 in cirrhotic patients.Cancer Sci. 2010 Aug;101(8):1905-12. doi: 10.1111/j.1349-7006.2010.01612.x. Epub 2010 May 8. Cancer Sci. 2010. PMID: 20550526 Free PMC article.
-
Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression.Cell Mol Life Sci. 2019 Jul;76(13):2647-2662. doi: 10.1007/s00018-019-03066-9. Epub 2019 Mar 22. Cell Mol Life Sci. 2019. PMID: 30903204 Free PMC article.
-
Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.Mol Cell Biol. 1997 Nov;17(11):6427-36. doi: 10.1128/MCB.17.11.6427. Mol Cell Biol. 1997. PMID: 9343405 Free PMC article.
-
Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions.Pathogens. 2014 Apr 23;3(2):377-89. doi: 10.3390/pathogens3020377. Pathogens. 2014. PMID: 25437805 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases